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Background: Tobacco smoking and red meat consumption are some of the known risk factors associated with
the development of oesophageal cancer. N-acetytransferases (NAT1 and NAT2) play a key role in metabolism of
carcinogenic arylamines present in tobacco smoke and overcooked red meat. We hypothesized that NAT1 and
NAT2 genetic polymorphisms may influence the risk of oesophageal cancer upon exposure to environmental
carcinogens.
Methods: Single nucleotide polymorphisms (SNPs) in the NAT1 and NAT2 genes were investigated by genotyping
732 cases and 768 healthy individuals from two South African populations to deduce the acetylator phenotype
(slow, intermediate or rapid) from the combination of the genotyped SNPs.
Results: The 341 CC genotype (rs1801280) was significantly associated with a reduced risk for oesophageal cancer in
the Mixed Ancestry population (OR = 0.31; 95% CI 0.11-0.87). The NAT2 slow/intermediate acetylator status significantly
increased the risk among cigarette smokers in the Black population (OR = 2.76; 95% CI 1.69-4.52), as well as among
alcohol drinkers in the Mixed Ancestry population (OR = 2.77; 95% CI 1.38-5.58). Similarly, the NAT1 slow/intermediate
acetylator status was a risk factor for tobacco smokers in the Black population (OR = 3.41; 95% CI 1.95-5.96) and for
alcohol drinkers in the Mixed Ancestry population (OR = 3.41; 95% CI 1.70-6.81). In a case-only analysis, frequent red
meat consumption was associated with a significantly increased cancer risk for NAT2 slow/intermediate acetylators in
the Mixed Ancestry population (OR = 3.55; 95% CI 1.29-9.82; P = 0.019), whereas daily white meat intake was associated
with an increased risk among NAT1 slow/intermediate acetylators in the Black population (OR = 1.82; 95% CI 1.09-3.04;
P = 0.023).
Conclusions: Our findings indicate that N-acetylation polymorphisms may modify the association between
environmental risk factors and oesophageal cancer risk and that N-acetyltransferases may play a key role in
detoxification of carcinogens. Prevention strategies in lifestyle and dietary habits may reduce the incidence of
oesophageal cancer in high-risk populations.
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Oesophageal squamous cell carcinoma (OSCC) is the most
common histological subtype of oesophageal cancer in de-
veloping countries and the main cause of cancer death in
Southern Africa, with incidence and mortality rates ap-
proximately 7-fold higher among men and 4-fold higher
among women than those in Northern Africa [1]. The
prevalence of oesophageal cancer varies widely between
different regions of South Africa, with exceptionally high-
incidence rates recorded in the Black African populations
of KwaZulu-Natal and the Eastern Cape [2]. The wide geo-
graphical variation in incidence of OSCC is most likely due
to both genetic and environmental factors [3]. A number
of epidemiological studies have pointed to tobacco smok-
ing and alcohol consumption as major environmental risk
factors for OSCC [4-6], and recent studies have also re-
ported a significant association between red meat intake
and an increased risk of oesophageal cancer [7,8].
Heterocyclic amines (HCAs) and nitrosamines are among
the major arylamine carcinogens present in tobacco smoke
and overcooked meat [9,10]. In humans these compounds
are metabolized by the Phase I and Phase II xenobiotic me-
tabolizing enzymes. The N-acetyltransferases (NATs) are
the main phase II xenobiotic metabolizing enzymes in-
volved in either detoxification or activation of arylamines,
depending on the nature of the substrate and the organ in-
volved [11]. The human NATs are encoded by two genes,
NAT1 [HGNC:7645; Ensembl:ENSG00000171428] and
NAT2 [HGNC:7646; Ensembl:ENSG00000156006], sepa-
rated by 170 kb on chromosome 8p21.3 − 23.1 [12].
Single nucleotide polymorphisms (SNPs) in the NAT1
and NAT2 genes alter the enzyme activity and are classi-
fied into rapid, intermediate or slow acetylators [13]. The
relationship between NAT2 polymorphisms and NAT2
acetylation activity has been widely investigated and a
strong genotype-phenotype correlation exists [14]. The
common SNPs in the coding region of the NAT2 gene,
191G>A, 341T>C, 590G>A, and 857G>A (referred to as
NAT2*14, NAT2*5, NAT2*6, and NAT2*7 alleles respect-
ively) lead to a significant decrease in acetylation activity
compared to the wild-type allele (NAT2*4), and are thus
designated as slow acetylator alleles [15]. A recent study
reported that genotyping of these SNPs is sufficient to
predict the NAT2 acetylator status with high accuracy
[16]. The NAT2*5, NAT2*6, and NAT2*7, and NAT2*14 al-
leles were observed at frequencies of 20%, 15%, 1.7%, and
2.5% in the South African Black population, respectively
[17]. The relationship between NAT1 polymorphisms and
NAT1 acetylation activity, on the other hand, has been
poorly investigated with inconsistent genotype-phenotype
correlation for SNPs that lie outside the coding region
[18]. The NAT1 polymorphisms in Black South Africans
are solely represented by NAT1*4 (wild-type), NAT1*10,
and NAT1*3 alleles, with frequencies of 49%, 50%, and 1%,respectively [19]. The NAT1*10 allele, inferred by the sim-
ultaneous presence of two SNPs (1088T>A and
1095C>A) within the 3’-UTR of the NAT1 gene, leads to
an alteration of the consensus polyadenylation signal and
is associated with a significantly increased acetylation ac-
tivity compared to the wild-type allele [20]. The NAT1*3
allele is inferred by the sole presence of 1095C>A, and
does not result in a significantly elevated acetylation activ-
ity compared to the wild-type allele [18].
The NAT1 and NAT2 polymorphic variants may influ-
ence the metabolism of arylamine carcinogens and modu-
late the individual susceptibility to cancer upon exposure to
environmental risk factors [21]. Genetic polymorphisms in
the NAT1 and NAT2 loci have been associated with suscep-
tibility to bladder, colon and rectal, breast, head and neck,
lung and prostate cancers (reviewed in [22]). However,
more consistent results were observed when the polymor-
phisms were investigated in association with environmental
exposure [23]. Previous studies have reported conflicting
results with regard to the role of NAT1 and NAT2 polymor-
phisms in oesophageal carcinogenesis [24-29].
We believe that genetic polymorphisms associated with
low N-acetylation activity may lead to an impaired deacti-
vation of arylamine carcinogens making subjects with slow
or intermediate acetylator status more susceptible to en-
vironmental or dietary carcinogens than those with the
rapid acetylator status. This study investigated the role of
NAT1 and NAT2 functional polymorphisms as independ-
ent risk factors for OSCC and as modifiers of the associ-
ation between environmental risk factors and OSCC in
two indigenous populations of South Africa.
Methods
Study group
The study group included 1500 South African subjects
subdivided into 463 OSCC patients and 480 control in-
dividuals from the Black population, and 269 OSCC
patients and 288 control individuals from the Mixed An-
cestry population. The Black individuals were mostly
Xhosa speakers residing in the Western Cape Province
of South Africa. The Mixed Ancestry individuals in the
Western Cape is an admixed population that originated
about 300 years ago from the union of different ethnic
groups, receiving ancestral contribution from the indigen-
ous Khoisan, sub-Saharan Africans, Europeans, Indonesians
and Malaysians [30].
All patients selected for the study were histologically di-
agnosed with squamous cell carcinoma of the oesophagus,
recruited between 2000 and 2012 from Groote Schuur
and Tygerberg Hospitals in Cape Town. The control
group included healthy volunteers with no history of any
cancer and no familial history of oesophageal cancer. They
were frequency matched to cases for geographical loca-
tion, ethnicity, sex, and age. Because oesophageal cancer is
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of control individuals set for the study was 50. However,
the control group had a higher proportion of individuals
below the age of 60, while the patients were mostly over
the age of 60. As a result, the mean age of the patients
was approximately three years higher than that in control
individuals in both the Black and Mixed Ancestry popula-
tion groups (Table 1).
Ethics approval was obtained from the joint University
of Cape Town/Groote Schuur Hospital Research Ethics
Committee and the University of Stellenbosch/Tygerberg
Hospital Ethics Committee. Written informed consent
was obtained from all study participants.
Definition of variables
The study participants completed a standard question-
naire to collect demographic (i.e. ethnicity, origin, lan-
guage, age, gender), lifestyle (i.e. smoking history, alcohol
consumption), and dietary (i.e. frequency and type of meat
intake) information.
The smoking habits were reported as smoking of
cigarettes, hand-rolled cigarettes, and pipes (all of which
referred to as ‘cigarettes’ in the text). Smoking is a qualita-
tive variable and subjects were classified as current
smokers (currently smoking at recruitment or stopped
smoking not earlier than one year prior to recruitment),
former smokers (smoked regularly at some point in their
lives for at least six months or quitted smoking at least
one year prior to recruitment), or never smokers (never
smoked). Current and former smokers were also asked to
report the number of cigarettes smoked per day and sub-
jects were grouped into those who smoked <10 cigarettes/
day and those who smoked ≥10 cigarettes/day.
Alcohol consumption status was defined according to
the frequency of alcohol (wine or beer) consumed per week
and subjects were subdivided into those who consumed
more than one litre of wine/beer per week and those who
consumed less than one litre of wine/beer per week.
The study participants were also asked to report their
average intake of red and white meat, fish, vegetables, and
fried food and grouped into those who consumed each
food category less than three times per week and those
who consumed them (almost) daily. Red meat included
beef, veal, pork, lamb, and offal. White meat included
chicken, turkey, and duck. Data on food consumption was
not available for control individuals, and only 299 Black
patients and 158 Mixed Ancestry patients (out of 463 and
269 total patients, respectively) provided information
about meat, fish, vegetables, and fried food intake.
Isolation and purification of DNA
Peripheral blood samples were collected from each sub-
ject enrolled in the study and stored at −20°C prior to
DNA extraction. Genomic DNA was extracted using astandard protocol [31]. All DNA samples were diluted to
a final concentration of 20 ng/μl in 96-well plates and
stored at −20°C until genotyping.
SNP selection and genotyping
Genotyping was determined blinded as to case-control
status and environmental exposure of study participants.
Four NAT2 SNPs; 191G>A (rs1801279), 341T>C
(rs1801280), 590G>A (rs1799930), and 857G>A (rs1799931),
were genotyped by TaqMan allele discrimination assay.
Each reaction was carried out in a 2.5 μl volume contain-
ing 1X Universal PCR Master Mix, 1X Drug Metabolism
Genotyping Assay Mix (Applied Biosystems), and 20 ng of
DNA. The thermal cycling conditions consisted of an
initial denaturation step at 95°C for 10 min, followed by
50 cycles of denaturation at 92°C for 15 sec and annealing/
extension at 60°C for 90 sec. The amplification reaction
and fluorescence measurement was performed in a Roche
LightCycler 480 II, and genotypes were assigned using SP4
1.5.0 software (Roche). Five NAT2 alleles were identified:
NAT2*4 (wild-type), NAT2*5, NAT2*6, NAT2*7 and
NAT2*14 (slow acetylator alleles). The acetylator pheno-
type was determined as follows: (i) subjects with two
NAT2*4 alleles were classified as “rapid” acetylators; (ii)
subjects with any combination of two slow acetylator al-
leles were “slow” acetylators; (iii) subjects with one
wild-type allele and one slow acetylator allele were
“intermediate” acetylators. Individuals carrying alleles
deducing either slow or intermediate acetylator status
were merged into one group, referred to as NAT2
“slow/intermediate” acetylators, and compared to rapid
acetylators (NAT2*4/*4).
Two NAT1 SNPs; 1095C>A (rs15561) and 1088T>A
(rs1057126), were determined by TaqMan assay as previ-
ously described [32]. We used a three-probe system to
genotype the two variants simultaneously in a single re-
action. This was necessary because the 1088/1095 SNPs
are too close to each other to use the conventional two-
probe TaqMan assay. Primers and hybridization probes
were designed according to the recommendations by
Roche Diagnostics Inc. [see Additional file 1]. 1X Univer-
sal PCR Master Mix (Applied Biosystems) was used as
PCR solution and primers, probes, and DNA were added
to final concentrations of 300 nM, 100 nM, and 8 ng/μl,
respectively. The amplification reaction was carried out in
a Roche LightCycler 480 II instrument with an initial hold
step at 95°C for 10 min followed by 40 cycles of a two-
step reaction (92°C for 15 s, 60°C for 1 min). Three NAT1
alleles were identified: NAT1*4 (wild-type), NAT1*3 and
NAT1*10 (rapid acetylator allele). Individuals with both
1095C>A and 1088T>A were referred to as NAT1*10
carriers, and those with only 1095C>A were NAT1*3
carriers. Subjects were classified as slow, intermediate,
or rapid acetylators if they had zero, one, or two copies
Table 1 Characteristics of the population study and effect of tobacco smoking, alcohol consumption, and red meat intake on OSCC risk
Black Mixed Ancestry
Demographic/risk factors Variables Controls (%) Cases (%) OR (95% CI)a P-value Controls (%) Cases (%) OR (95% CI)a P-value
Gender Males 235 (49) 229 (49) 178 (62) 177 (66)
Females 245 (51) 234 (51) 110 (38) 92 (34)
Age Mean (SDb) 56.7 (15.0) 59.6 (10.7) 57.7 (14.3) 60.7 (10.3)
Tobacco smoking Never smokers 258 (54) 181 (39) 1 (Ref) 62 (22) 15 (6) 1 (Ref)
Smokersc 222 (46) 280 (60) 1.79 (1.39-2.33) <0.0001 226 (78) 250 (93) 4.57 (2.53-8.27) <0.0001
Unknown 0 (0) 2 (0.4) 0 (0) 4 (1)
Total cigarettes/day 0 258 (54) 181 (39) 1 (Ref) 62 (21) 15 (6) 1 (Ref)
<10 137 (28) 179 (39) 1.86 (1.39-2.49) <0.0001 118 (41) 85 (31) 2.98 (1.59-5.59) 0.001
≥10 73 (15) 95 (20) 1.85 (1.29-2.66) 0.001 90 (31) 160 (59) 7.35 (3.95-13.6) <0.0001
Unknown 12 (2) 8 (2) 18 (6) 9 (3)
Alcohol drinking Non-drinkers 201 (42) 175 (38) 1 (Ref) 115 (40) 51 (19) 1 (Ref)
Drinkersd 278 (58) 286 (62) 1.18 (0.91-1.53) 0.211 172 (60) 215 (80) 2.82 (1.92-4.15) <0.0001
Unknown 1 (0.2) 2 (0.4) 1 (0.3) 3 (1)
Tobacco smoking + alcohol drinking Never smokerse 257 (53) 180 (39) 1 (Ref) 62 (21) 15 (6) 1 (Ref)
Smokers/non-drinkers 41 (8) 33 (7) 1.15 (0.70-1.89) 0.583 75 (26) 37 (14) 2.04 (1.02-4.06) 0.042
Smokers/drinkers 181 (38) 247 (53) 1.95 (1.49-2.55) <0.0001 150 (52) 213 (79) 5.87 (3.22-10.7) <0.0001
Unknown 1 (0.2) 3 (0.6) 1 (0.3) 4 (1)
Red meat intake 3 times/week or less − 261 (56) − 108 (40)
Daily or almost daily − 37 (8) − 50 (19)
Unknown − 165 (36) − 111 (41)
White meat intake 3 times/week or less − 151 (33) − 75 (28)
Daily or almost daily − 148 (32) − 82 (30)
Unknown − 164 (35) − 112 (42)
Fish 3 times/week or less − 289 (62) − 146 (54)
Daily or almost daily − 9 (2) − 11 (4)
Unknown − 165 (36) − 112 (42)
Vegetables 3 times/week or less − 243 (52) − 54 (20)
Daily or almost daily − 53 (11) − 101 (37)












Table 1 Characteristics of the population study and effect of tobacco smoking, alcohol consumption, and red meat intake on OSCC risk (Continued)
Fried food 3 times/week or less − 291 (63) − 135 (50)
Daily or almost daily − 5 (1) − 20 (7)
Unknown − 167 (36) − 114 (42)
aCrude odds ratio was calculated.
bSD = standard deviation of the mean.
cSmokers = current and former smokers.
dDrinkers = light to heavy alcohol drinkers.
eNever smokers (including drinkers and non-drinkers).
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either zero or one copy of NAT1*10 allele were merged
into one group, referred to as NAT1 “slow/intermedi-
ate” acetylators, and compared to rapid acetylators
(NAT1*10/*10).Statistical analysis
Genotype counts among controls were tested for devi-
ation from Hardy-Weinberg Equilibrium using the Chi-
Square test with one degree of freedom [33].
The genetic association analyses were performed as-
suming a multiplicative genetic model for any risk allele
or risk category. Where sample sizes were sufficiently
large, we tested for differences in frequency distribution
between cases and control individuals using Pearson’s
Chi-Square (χ2) test of association. Crude odds ratio
(OR), adjusted odds ratio, 95% confidence interval (95%
CI), and P-value for association were estimated for the
tested allele or category. The adjustment of the OR
for potential confounders such as age, gender, tobacco
smoking, and alcohol consumption was computed by
using multivariate conditional logistic analysis [the dis-
ease status (case/control) was checked against each poly-
morphism (GG/GA/AA) for all the cases and controls
used in the study by considering also other variables
such as smoking, alcohol consumption, age and sex]. All
reported P-values are two-sided and a P-value <0.05 was
considered as significant. A conservative P-value thresh-
old of 0.0042 (=0.05/[2x6]) was used to assess the signifi-
cance of association applying Bonferroni correction for
multiple testing of the six genotyped SNPs in the two
populations.
Case-only analyses were performed to evaluate the
interaction between the acetylation polymorphism and
meat consumption by testing for frequency of red and
white meat intake (<3 times per week/almost daily).
All statistical analyses were performed using SPSS 19
software package (SPSS, Chicago, IL). Linkage disequilib-
rium and haplotype analyses were performed on the
control groups using Haploview [34]. The pairwise link-
age disequilibrium was measured by variables DI and r2.
Pearson’s χ2 was used to test for differences in haplotype
distribution between patients and control individuals
using UNPHASED [35].Results
Demographic details and environmental exposure
The distribution of demographic details and lifestyle fac-
tors among cases and control individuals enrolled in the
study is shown in Table 1. The percentages of tobacco
smokers, alcohol drinkers, and of subjects that consumed
red meat, fried food, and vegetables daily were higher in
the Mixed Ancestry group than in the Black group, whileno significant difference was observed for daily consump-
tion of white meat and fish.
Tobacco smoking was associated with a significantly
increased risk of OSCC among both the Black (OR =
1.79; 95% CI 1.39-2.33; P < 0.0001) and Mixed Ancestry
(OR = 4.57; 95% CI 2.53-8.27; P <0.0001) individuals. In
the Mixed Ancestry group, the risk associated with to-
bacco smoking increased with the number of cigarettes
smoked per day, with a 2.98-fold higher risk (95% CI
1.59-5.59; P = 0.001) among those smoking <10 ciga-
rettes/day, and a 7.35-fold higher risk (95% CI 3.95-
13.66; P < 0.0001) among those smoking ≥10 cigarettes/
day, compared to never smokers. No cumulative effect
of tobacco smoking on OSCC risk was observed in the
Black group.
A higher proportion of alcohol drinkers was observed
among patients compared to control individuals in both
ethnic groups, although the difference was significant
only in the Mixed Ancestry group (OR = 2.82; 95% CI
1.92-4.15; P < 0.0001). The analysis of the combined effect
of tobacco smoking and alcohol consumption showed a
significantly higher OSCC risk for smokers who drank al-
cohol (‘smokers/drinkers’) compared to ‘never smokers’
(including drinkers and non-drinkers) among both Black
(OR = 1.95; 95% CI 1.49-2.55; P < 0.0001) and Mixed
Ancestry (OR = 5.87; 95% CI 3.22-10.71; P <0.0001) indi-
viduals. No increased risk was observed for ‘smokers/non-
drinkers’ in the Black group (P = 0.583), while only a weak
association was detected in the Mixed Ancestry group
(OR = 2.04; 95% CI 1.02-4.06; P = 0.042).Linkage disequilibrium analysis
The results of the linkage disequilibrium analysis (LD)
and Hardy-Weinberg equilibrium tests in the two South
African populations showed that the distribution of ge-
notypes for each SNP in the control groups were in
Hardy-Weinberg equilibrium (P > 0.05; see Additional
file 2). The NAT1 1088T>A and 1095C>A SNPs oc-
curred at high frequency (MAF ≥ 0.401) and were in
complete LD in both ethnic groups (DI = 1.0). For the
NAT2 SNPs, only 341T>C (NAT2*5) and 590G>A
(NAT2*6) were present at relatively high frequencies
(MAF ≥ 0.214) and strong LD (DI = 1.0) existed between
these two polymorphisms in both population groups. Link-
age disequilibrium of 857G>A (NAT2*7) and 191G>A
(NAT2*14) with other SNPs was not considered because of
the low frequency of these two polymorphic variants in
both population groups (MAF ≤ 0.063). No significant LD
was observed between SNPs in the NAT1 locus and the
two most common SNPs in the NAT2 locus (341T>C and
590G>A) in either ethnic group, thereby forming two main
LD blocks, Block 1 (including NAT1 SNPs) and Block 2
(including NAT2 SNPs), as shown in Figure 1.
Figure 1 Linkage disequilibrium between NAT1 and NAT2 SNPs in Black and Mixed Ancestry South Africans. Plots show r2 and D’ values
for pairwise LD between NAT1 and NAT2 variants in the South African Black and Mixed Ancestry population groups. The left triangle in each plot
represents NAT1 SNPs, while the right triangle represents NAT2 SNPs. Colour intensity of squares (black to white) indicates the strength of LD
(high to low) by D’, while numbers within squares refer to r2 values for pairwise SNPs. D’ and r2 refer to different statistical methods to measure
linkage disequilibrium between alleles; r2 is preferred to predict one allele given the other, whereas D’ is mainly used to assess recombination
patterns such as haplotype blocks. Linkage disequilibrium analysis was carried out in control groups by using Haploview [34].
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A significant association was detected among carriers of
the 341 CC variant genotype (NAT2*5/*5) compared to
carriers of the wild-type (341 TT) genotype (OR = 0.31;
95% CI 0.11-0.87; P = 0.026) in the Mixed Ancestry
population, with a borderline association in the Black
population (OR = 0.55; 95% CI 0.30-0.99; P = 0.05)
(Table 2). The NAT2 341 C allele (NAT2*5) was associ-
ated with a reduced risk for OSCC in the Mixed Ances-
try group (OR = 0.57; 95% CI 0.38-0.87; P = 0.010), while
no significant association was found in the Black group
(OR = 0.82; 95% CI 0.64-1.06; P = 0.132; see Additional
file 3). However, none of the associations observed in
the Mixed Ancestry population had significance below
the Bonferroni corrected P-value of 0.0042.
The distribution of NAT2 acetylator phenotypes (rapid,
intermediate, and slow acetylators) between cases and
control individuals was significantly different in the
Mixed Ancestry group, while no significant difference
was observed in the Black group, even when intermediate
and slow acetylators were merged into one group and
compared with the rapid acetylators (Table 3). For the
Mixed Ancestry individuals, the NAT2 slow/intermediate
acetylators were at reduced risk of OSCC compared with
rapid acetylators (OR = 0.44; 95% CI 0.27-0.70; P = 0.001),
while the NAT1 slow/intermediate acetylator status was
not a risk factor for OSCC (OR = 0.85; 95% CI 0.43-1.68;
P = 0.638). For the Black individuals, the ORs were 0.78
(95% CI 0.55-1.11; P = 0.166) for NAT1 slow/intermediate
acetylators and 0.82 (95% CI 0.54-1.23; P = 0.333) forNAT2 slow/intermediate acetylators compared to their re-
spective rapid acetylator groups.
The effect of NAT1 and NAT2 acetylator phenotypes on
the association of tobacco smoking and alcohol consump-
tion with OSCC risk was investigated by case-control ana-
lysis (Tables 4 and 5).
In the Black group, smoking was associated with a sig-
nificantly increased risk of OSCC for the NAT2 slow/inter-
mediate acetylators, with an OR of 2.76 (95% CI 1.69-4.52;
P < 0.0001) among smokers compared to never smokers,
while tobacco smoking was not a risk factor for the NAT2
rapid acetylators (OR = 2.58; 95% CI 0.80-8.25; P = 0.111;
Table 4). Similarly, the smoking-associated risk for OSCC
was significantly higher for NAT1 slow/intermediate acety-
lators (OR = 3.41; 95% CI 1.95-5.96; P < 0.0001), whereas
no significant association was observed for NAT1 rapid
acetylators (OR = 1.71; 95% CI 0.73-4.04; P = 0.218;
Table 5). However, heterogeneity testing for NAT2 slow/
intermediate acetylators vs rapid acetylators (I2 = 0%; P =
0.917) and for NAT1 slow/intermediate acetylators vs rapid
acetylators (I2 = 42.9%; P = 0.185) indicated that smoking
might increase the risk for OSCC in Black subjects regard-
less of their acetylator status. The effect of NAT1 and
NAT2 polymorphisms on the smoking-associated risk of
OSCC was not evaluated in the Mixed Ancestry group be-
cause of the extremely low number of non-smokers in this
group.
The alcohol-related risk of OSCC in the Mixed Ances-
try population was significantly increased for NAT1
slow/intermediate acetylators (OR = 3.41; 95% CI 1.70-
6.81; P = 0.001) and NAT2 slow/intermediate acetylators
Table 2 Genotype frequency of NAT2 and NAT1 polymorphisms and association with OSCC in Black and Mixed Ancestry South Africans
Black Mixed Ancestry
Gene SNP Polymorphism Controls (%) Cases (%) OR (95% CI)a P-value Controls (%) Cases (%) OR (95% CI)a P-value
NAT2 590G>A G / G 296 (62.3) 257 (57.2) 1 (Ref) - 172 (59.7) 159 (60.0) 1 (Ref) -
(NAT2*6) G / A 155 (32.6) 163 (36.3) 1.20 (0.85 - 1.69) 0.299 105 (36.4) 93 (35.1) 0.69 (0.39 - 1.21) 0.192
rs1799930 A / A 24 (5.0) 29 (6.4) 1.46 (0.72 - 2.94) 0.291 11 (3.8) 13 (4.9) 1.30 (0.34 - 4.91) 0.697
341T>C T / T 247 (52.1) 237 (53.0) 1 (Ref) - 130 (45.1) 147 (55.7) 1 (Ref) -
(NAT2*5) T / C 179 (37.8) 178 (39.8) 0.97 (0.69 - 1.36) 0.856 125 (43.4) 101 (38.2) 0.59 (0.34 - 1.04) 0.069
rs1801280 C / C 48 (10.1) 32 (7.1) 0.55 (0.30 - 0.99) 0.05 33 (11.5) 16 (6.1) 0.31 (0.11 - 0.87) 0.026
857G>A G / G 471 (98.9) 440 (98.2) 1 (Ref) - 265 (92.0) 237 (90.5) 1 (Ref) -
(NAT2*7) G / A 5 (1.0) 7 (1.6) 0.95 (0.19 - 4.77) 0.948 23 (8.0) 24 (9.2) 1.32 (0.54 - 3.23) 0.548
rs1799931 A / A 0 (0) 1 (0.2) − 0 (0) 1 (0.4) −
191G>A G / G 417 (87.6) 402 (90.1) 1 (Ref) - 275 (95.5) 244 (92.8) 1 (Ref) -
(NAT2*14) G / A 58 (12.2) 41 (9.2) 0.78 (0.46 - 1.33) 0.364 13 (4.5) 18 (6.8) 1.46 (0.48 - 4.49) 0.508
rs1801279 A / A 1 (0.2) 3 (0.7) − 0 (0) 1 (0.4) −
NAT1 1088T>A T / T 89 (19.2) 100 (22.8) 1 (Ref) - 106 (37.3) 81 (31.4) 1 (Ref) -
(NAT1*10) T / A 219 (47.3) 196 (44.7) 0.77 (0.50 - 1.18) 0.226 128 (45.1) 130 (50.4) 1.64 (0.90 - 2.98) 0.103
rs1057126 A / A 155 (33.5) 142 (32.4) 1.07 (0.67 - 1.70) 0.781 50 (17.6) 47 (18.2) 1.57 (0.73 - 3.40) 0.249
1095C>A C / C 86 (18.6) 95 (21.7) 1 (Ref) - 97 (34.1) 69 (26.7) 1 (Ref) -
(NAT1*10, NAT1*3) C / A 220 (47.5) 198 (45.2) 0.79 (0.51 - 1.23) 0.299 130 (45.8) 138 (53.5) 1.83 (0.99 - 3.39) 0.054
rs15561 A / A 157 (33.9) 145 (33.1) 1.10 (0.69 - 1.75) 0.681 57 (20.1) 51 (19.8) 1.78 (0.82 - 3.84) 0.143
Samples with unknown genotype are not shown.
aOdds ratio was adjusted for age, gender, tobacco smoking, and alcohol consumption status; odds ratio was not calculated for subgroups with low sample size.












Table 3 Distribution of NAT1 and NAT2 acetylation polymorphisms and association with OSCC in the Black and Mixed
Ancestry populations
Black Mixed Ancestry
Gene Acetylator status Controls (%) Cases (%) OR (95% CI)a P-value Controls (%) Cases (%) OR (95% CI)a P-value
NAT2 Rapid 87 (18) 90 (19) 1 (Ref) 49 (17) 57 (21) 1 (Ref)
Intermediate 231 (48) 192 (41) 0.77 (0.50-1.20) 0.248 124 (43) 113 (42) 0.47 (0.28-0.80) 0.004
Slow 155 (32) 161 (35) 0.88 (0.56-1.39) 0.588 115 (40) 91 (34) 0.40 (0.24-0.68) 0.001
Unknown 7 (1) 20 (4) 0 (0) 8 (3)
Slow + intermediate 386 (82) 353 (79) 0.82 (0.54-1.23) 0.333 239 (83) 204 (78) 0.44 (0.27-0.70) 0.001
NAT1 Rapid 155 (32) 142 (31) 1 (Ref) 50 (17) 47 (17) 1 (Ref)
Intermediate 219 (46) 196 (42) 0.72 (0.49-1.05) 0.084 128 (44) 130 (48) 1.04 (0.50-2.17) 0.908
Slow 89 (18) 100 (22) 0.94 (0.59-1.48) 0.781 106 (37) 81 (30) 0.64 (0.29-1.37) 0.249
Unknown 17 (3) 25 (5) 4 (1) 11 (4)
Slow + intermediate 308 (66) 296 (68) 0.78 (0.55-1.11) 0.166 234 (82) 211 (81) 0.85 (0.43-1.68) 0.638
aOdds ratio was adjusted for age, gender, tobacco smoking, and alcohol consumption status.
Ref = reference allele.
NAT2 rapid = NAT2*4/*4.
NAT2 intermediate = NAT2*4/*5, NAT2*4/*6, NAT2*4/*7, or NAT2*4/*14.
NAT2 slow = any combination of NAT2*5, NAT2*6, NAT2*7, and NAT2*14.
NAT1 rapid = NAT1*10/*10.
NAT1 intermediate = NAT1*10/*4 or NAT1*10/*3.
NAT1 slow = NAT1*4/*4, NAT1*4/*3, or NAT1*3/*3.
*Indicates the allele for each of the genes.
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creased risk was observed for alcohol drinkers who were
either NAT1 rapid acetylators (OR = 0.80; 95% CI 0.19-
3.44; P = 0.764) or NAT2 rapid acetylators (OR = 2.43;
95% CI 0.65-9.15; P = 0.188). However, heterogeneity
testing for NAT2 slow/intermediate acetylators vs rapid
acetylators (I2 = 0%; P = 0.864) suggested that alcohol
may be a significant risk factor for OSCC in both NAT2
acetylator groups, while substantial heterogeneity be-
tween the NAT1 acetylator phenotypes (I2 = 68.1%; P =
0.077) suggested thatNAT1 acetylator status may modify
the alcohol-associated risk of OSCC among Mixed An-
cestry individuals. In the Black population, the acetyl-
ation polymorphism had no effect on the association
between alcohol intake and OSCC risk (Tables 4 and 5).
A case-only analysis was performed to investigate the
interaction of NAT1 and NAT2 acetylator phenotypes with
meat consumption on susceptibility to OSCC. In the Mixed
Ancestry patients, daily intake of red meat was significantly
more frequent amongNAT2 slow/intermediate acetylators
than among NAT2 rapid acetylators (OR = 3.55; 95% CI
1.29-9.82; P = 0.019), whereas no significant difference was
observed among Black patients (OR = 1.67; 95% CI 0.61-
4.58; P = 0.316; Table 4). No interaction between NAT1
acetylator phenotypes and red meat consumption was ob-
served among either Black patients (OR = 0.93; 95% CI
0.43-2.0; P = 0.851) or Mixed Ancestry patients (OR = 1.32;
95% CI 0.49-3.55; P = 0.586). We also observed a statisti-
cally significant interaction between daily consumption of
white meat and the NAT1 slow acetylator status in Blackpatients (OR = 1.82; 95% CI 1.09-3.04; P = 0.023), while
such interaction was not significant in Mixed Ancestry pa-
tients (OR = 1.58; 95% CI 0.68-3.67; P = 0.288; Table 5).Discussion
We determined the distribution of the NAT1*3, NAT1*4,
NAT1*10, NAT2*4, NAT2*5, NAT2*6, NAT2*7, and
NAT2*14 alleles in the Black and Mixed Ancestry popu-
lations of South Africa, accounting for the majority of
the NAT1 and NAT2 alleles observed in Black South
Africans and Caucasians [19].
The overall frequency of the NAT2 slow acetylator alleles
in Black Xhosa and Mixed Ancestry healthy individuals
(57.2% and 61.5%, respectively) was similar to that previ-
ously reported in the Black Tswana and Mixed Ancestry
populations from South Africa (59% and 54%, respectively)
[19,36]. The allele frequency of NAT1*10 observed in Black
Xhosa (57.1%) was similar to that previously reported in
Black Tswana (50.5%), whereas the frequency in Mixed
Ancestry individuals (40.1%) was closer to that observed
in Black South Africans than that of UK Caucasians
(18.7%) [19].
The high LD observed between 341T>C (NAT2*5) and
590G>A (NAT2*6) in both South African populations has
also been reported in a Northern Indian population [26].
Although studies reported a strong LD between NAT1*10
and NAT2*4 in Caucasians [37,38], we found no signifi-
cant LD between NAT1 and NAT2 alleles in South
Africans.
Table 4 Association of NAT2 acetylator phenotype with OSCC risk upon exposure to environmental risk factors in Black and Mixed Ancestry South Africans
NAT2 rapid acetylators NAT2 slow/intermediate acetylators
Population Risk factors Variables Controls Cases OR (95% CI)a P-value Controls Cases OR (95% CI)a P-value
Black
Tobacco smoking Never smokers 49 39 1 (Ref) 206 132 1 (Ref)
Smokersb 38 51 2.58 (0.80-8.25) 0.111 180 220 2.76 (1.69-4.52) <0.0001
Tot cigarettes/day 0 49 39 1 (Ref) 206 132 1 (Ref)
≤9 23 31 2.23 (0.67-7.36) 0.189 112 143 3.27 (1.93-5.54) <0.0001
≥10 13 19 3.79 (0.92-15.7) 0.066 58 72 2.49 (1.34-4.62) 0.004
Alcohol drinking Non-drinkers 34 39 1 (Ref) 164 127 1 (Ref)
Drinkersc 53 51 0.94 (0.34-2.62) 0.903 221 224 0.91 (0.59-1.41) 0.675
Red meat intaked 3 times/week or less − 55 − 198 1 (Ref)
Daily or almost daily − 5 − 31 1.67 (0.61-4.58) 0.316
White meat intaked 3 times/week or less − 33 − 113 1 (Ref)
Daily or almost daily − 27 − 117 1.28 (0.72-2.29) 0.397
Mixed Ancestry
Tobacco smoking Never smokers 8 2 1 (Ref) 54 12 1 (Ref)
Smokersb 41 53 − − 185 191 − −
Tot cigarettes/day 0 8 2 1 (Ref) 54 12 1 (Ref)
≤9 22 25 − − 96 58 − −
≥10 16 27 − − 74 129 − −
Alcohol drinking Non-drinkers 15 9 1 (Ref) 100 41 1 (Ref)
Drinkersc 34 47 2.43 (0.65-9.15) 0.188 138 162 2.77 (1.38-5.58) 0.004
Red meat intaked 3 times/week or less − 31 − 75 1 (Ref)
Daily or almost daily − 5 − 43 3.55 (1.29-9.82) 0.019
White meat intaked 3 times/week or less − 20 − 51 1 (Ref)
Daily or almost daily − 16 − 66 1.80 (0.81-4.02) 0.149
Samples with unknown acetylator status are not shown.
Ref = reference allele.
aOR was adjusted for age, gender, smoking and alcohol consumption status; OR was not calculated for subgroups with low sample size.
bSmokers = current and former smokers.
cDrinkers = light to heavy alcohol drinkers.












Table 5 Association of NAT1 acetylator phenotype with OSCC risk upon exposure to environmental risk factors in Black and Mixed Ancestry South Africans
NAT1 rapid acetylators NAT1 slow/intermediate acetylators
Population Risk factors Variables Controls Cases OR (95% CI)a P-value Controls Cases OR (95% CI)a P-value
Black
Tobacco smoking Never smokers 84 61 1 (Ref) 166 109 1 (Ref)
Smokersb 71 81 1.71 (0.73-4.04) 0.218 142 186 3.41 (1.95-5.96) <0.0001
Tot cigarettes/day 0 84 61 1 (Ref) 166 109 1 (Ref)
≤9 45 50 1.80 (0.72-4.53) 0.208 87 123 3.96 (2.19-7.13) <0.0001
≥10 24 31 2.06 (0.73-5.84) 0.174 45 57 2.97 (1.47-5.99) 0.002
Alcohol drinking Non-drinkers 66 53 1 (Ref) 130 112 1 (Ref)
Drinkersc 89 89 1.17 (0.52-2.59) 0.707 177 182 0.87 (0.54-1.40) 0.570
Red meat intake d 3 times/week or less − 81 − 168 1 (Ref)
Daily or almost daily − 12 − 23 0.93 (0.43-2.0) 0.851
White meat intaked 3 times/week or less − 56 − 87 1 (Ref)
Daily or almost daily − 38 − 104 1.82 (1.09-3.04) 0.023
Mixed Ancestry
Tobacco smoking Never smokers 17 1 1 (Ref) 43 14 1 (Ref)
Smokersb 33 46 − − 191 194 − −
Tot cigarettes/day 0 17 1 1 (Ref) 43 14 1 (Ref)
≤9 17 24 − − 101 58 − −
≥10 11 20 − − 77 133 − −
Alcohol drinking Non-drinkers 21 12 1 (Ref) 93 39 1 (Ref)
Drinkersc 29 35 0.80 (0.19-3.44) 0.764 140 170 3.41 (1.70-6.81) 0.001
Red meat intaked 3 times/week or less − 22 − 81 1 (Ref)
Daily or almost daily − 7 − 42 1.32 (0.49-3.55) 0.586
White meat intaked 3 times/week or less − 16 − 56 1 (Ref)
Daily or almost daily − 13 − 66 1.58 (0.68-3.67) 0.288
Samples with unknown acetylator status are not shown.
Ref = reference allele.
aOR was adjusted for age, gender, smoking and alcohol consumption status; OR was not calculated for subgroups with low sample size.
bSmokers = current and former smokers.
cDrinkers = light to heavy alcohol drinkers.
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ation between tobacco smoking and a high risk of OSCC
in the Black and Mixed Ancestry populations from
South Africa, as well as a cumulative risk associated with
the number of cigarettes smoked per day in the Mixed
Ancestry population [4]. Alcohol consumption was an
independent risk factor only in the Mixed Ancestry
population, but no association was observed in the Black
Xhosa population, which is in agreement with the results
from a previous study conducted in the same ethnic
groups [4]. We also confirmed the previously reported
combined effect of alcohol consumption and tobacco
smoking on the enhanced oesophageal cancer risk in
Black South Africans [39]. Furthermore, tobacco smok-
ing, alcohol consumption, and frequent red meat intake
were more prevalent in the Mixed Ancestry population
than in the Black population, indicating that Mixed An-
cestry South Africans may be more exposed to environ-
mental carcinogens than Black South Africans.
The NAT2 341T>C (NAT2*5) polymorphism and NAT2
slow/intermediate acetylator status were associated with a
significantly reduced risk of OSCC in the Mixed Ancestry
population. Because NAT2*5 is a slow acetylator allele and
NATs are able to activate arylamine carcinogens to reactive
intermediates [11,15], the NAT2 slow acetylator status may
result in an enzyme with impaired N-acetylation capacity,
possibly leading to reduced production of reactive interme-
diates and ultimately preventing DNA damage and carcino-
genesis. NAT2*5 is the most frequent NAT2 allele in the
South African population, and has the greatest reduction in
acetylation activity among NAT2 slow acetylator alleles
[40]. These findings may explain why the association with
OSCC was observed among the NAT2*5 allele carriers and
not among subjects carrying other NAT2 slow acetylator
alleles. A recent study in a Chinese population found the
CC genotype of the NAT2 rs1565684 T >C polymorphism
to be associated with a borderline significantly increased
risk for OSCC (OR= 1.77; 95% CI 0.97–3.21; P = 0.063).
Although this variant has been reported to be functional
and in LD with another important NAT2 polymorphism
(rs4345600; r2 = 0.845) in the Han Chinese, the etiology of
NAT2 rs1565684 on oesophageal carcinogenesis is still un-
known [41]. In accordance with a previous study on
oesophageal adenocarcinoma [29], we found no statistically
significant association between NAT1 polymorphisms
(NAT1*10 and *3) and OSCC risk in both South African
populations.
When we evaluated the association between the NAT1
and NAT2 acetylator phenotypes and OSCC risk in con-
junction with environmental exposure, the risk associated
with tobacco smoking and alcohol intake appeared to be
higher among slow/intermediate acetylators than among
rapid acetylators, although this difference was not signifi-
cant. The lack of a significant association between smokingand alcohol intake with OSCC among rapid acetylators is
probably due to the small sample size of these subgroups
and the resulting low statistical power to detect significant
associations. The interaction of the NAT1 and NAT2 poly-
morphisms with tobacco smoking or red meat intake is
likely to be due to the role of NATs in the metabolism of
HCAs and nitrosamines, which are the most relevant car-
cinogen in tobacco smoke and overcooked meat [9,10].
Our finding of an interaction between NAT1 acetylator sta-
tus and white meat intake in the Black population is in
agreement with a study showing that heat-treated poultry
products have significant amounts of HCAs based on
the cooking methods and conditions [42]. Furthermore,
a previous cohort study reported a significant positive
association between poultry intake and oesophageal
adenocarcinoma risk [43]. Slow and intermediate acety-
lators may be unable to detoxify carcinogenic metabo-
lites efficiently; therefore, an impaired detoxification of
HCA- and nitrosamine-derived metabolites may explain
the greater risk of OSCC associated with low N-acetylation
activity upon exposure to environmental carcinogens. How-
ever, no study to date has biologically demonstrated that
low N-acetylation activity leads to an impaired deactivation
of arylamine carcinogens in humans.
A recent cohort study identified statistically significant
positive associations of both heme iron (HR = 1.67; 95%
CI 1.05–2.68; P = 0.022) and processed red meat intake
(HR = 2.27; 95% CI 1.33–3.89; P = 0.004) with oesophageal
adenocarcinoma [44]. Heme iron is an organic form of
iron and is mainly provided by red meat. It has been dem-
onstrated that heme iron specifically contributes to car-
cinogenesis by increasing oxidative stress or by catalysing
endogenous formation of nitroso-compounds [45,46].
Thus, the N-nitrosation induced by heme iron may in-
crease the level of nitrosamines in humans and ultimately
contribute to oesophageal carcinogenesis in slow/inter-
mediate acetylators [44].
We observed that NAT1 and NAT2 acetylator pheno-
types modify the alcohol-associated risk of OSCC in the
Mixed Ancestry population. Ethanol from alcoholic bever-
ages can cause local irritation of the upper gastrointestinal
tract and can act as solvent for tobacco-related carcino-
gens, facilitating their uptake through the oesophageal
mucosa [47]. Furthermore, studies in vitro and in vivo re-
ported that acetaldehyde, a metabolite of ethanol oxida-
tion, has direct mutagenic and carcinogenic properties on
human tissues [48]. A previous study did not find a modu-
lating effect of NAT2 polymorphisms on the association
between alcohol consumption and OSCC risk [26]; how-
ever, another study suggested a direct role of NAT2 in the
metabolism of alcohol-derived carcinogens [49]. Impair-
ment of aldehyde dehydrogenase 2 (ALDH2), a major en-
zyme involved in alcohol metabolism, has been associated
with acetaldehyde-derived DNA damage in the oesophagus
Matejcic et al. BMC Cancer  (2015) 15:150 Page 13 of 14following alcohol ingestion [50]. It is therefore possible
that the alcohol-associated risk of OSCC observed among
slow/intermediate acetylators in the Mixed Ancestry
population may occur by a similar mechanism.
This study assessed the role of NAT1 polymorphisms
on susceptibility to OSCC, the interaction of NATs with
alcohol and meat consumption on OSCC risk, and the
role of NATs on cancer susceptibility in African popula-
tions. A limitation of the study was the lack of data for
control individuals with regard to red and white meat in-
take and the cooking and preparation methods of the
meat. Therefore, some caution must be taken when
drawing interpretations of the results on the association
between meat consumption and oesophageal cancer risk.
Conclusions
In conclusion, we provide evidence of tobacco smoking,
alcohol consumption, and meat intake as independent risk
factors for OSCC in South Africa. The main finding of this
study is that NAT1 and NAT2 polymorphisms may modu-
late the risk of OSCC upon exposure to environmental
risk factors in two indigenous populations of South Africa,
indicating that NATs play a key role in detoxification of
carcinogens responsible for the initiation of oesophageal
cancer. Our findings may offer opportunities to adopt pre-
vention strategies in lifestyle and dietary habits aimed at
reducing the exposure to environmental risk factors and
at preventing the occurrence of oesophageal cancer in
high-risk populations of South Africa.
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